- Home
- Members
- Professor Emmanouil (Manolis) Dermitzakis
- Alexandra Cristina Nica
- Tuuli Lappalainen
- Ancilla Stefani
- Maria Gutierrez-Arcelus
- Luciana Romano
- Alfonso Buil Demur
- Ismael Padioleau
- Alexandra Planchon
- Alisa Yurovsky
- Halit Ongen
- Julien Bryois
- Helena Kilpinen
- Deborah Penet
- Daniel Robyr
- Nikos Panousis
- Cibele Masotti
- Diogo Meyer
- Pedro Dias Ferreira
- Olivier Delaneau
- Cédric Howald
- Anastasia Niarchou
- Andrew Brown
- Ana Viñuela
- Christelle Stouder
- Isabelle Stévant
- Marco Garieri
- Stéphane Dupuis
- Carolin Vegvari
- Michael Stevens
- Ambra Sartori
- Vitor Aguiar
- Pauline Sararols
- Christelle Borel
- Chloe Mayere
- Nikolaos Michail Rafail Lykoskoufis
- Aline Real
- Guillaume Rey
- About Us
- Publications
- Data
- Internal
- Leena Peltonen School of Human Genomics 2018
Professor Emmanouil (Manolis) Dermitzakis
Professor: Department of Genetic Medicine and Development / Director: Health 2030 Genome Center
Email: Emmanouil.Dermitzakis[at]unige.ch
Emmanouil (Manolis) Dermitzakis is currently Director of the Health 2030 Genome Center and Professor of Genetics in the Department of Genetic Medicine and Development of the University of Geneva Medical School. He is a member of the Executive Boards of Swiss Personalized Health Network (SPHN) and the Institute of Genetics and Genomics in Geneva (iGE3), a member of the Swiss Institute of Bioinformatics, and is also an affiliated Faculty member at the Biomedical Research Foundation of the Academy of Athens in Greece. He obtained his B.Sc. in 1995 and M.Sc. in 1997 in Biology from the University of Crete (Greece) and his PhD in 2001 from the Pennsylvania State University in the USA, studying the evolutionary biology and population genetics of regulatory DNA in mammals and Drosophila. His post-doctoral work was at the University of Geneva Medical School, focusing on comparative genome analysis and the functional characterization of conserved non-genic elements. He was an Investigator and Senior Investigator at the Wellcome Sanger Institute between 2004 and 2009. His current research focuses on the genetic basis of cellular phenotypes, complex traits and disease and precision medicine. He has authored and co-authored more than 160 papers in peer-reviewed journals, many of them in journals such as Nature, Science and Nature Genetics. His research has been supported by the Louis-Jeantet Foundation, the Wellcome Trust, the Swiss National Science Foundation, the European Commission, the Juvenile Diabetes Foundation and the US National Institutes of Health (NIH). He is also the recipient of a European Research Council (ERC) grant. His H-index is 90 and his work has been cited >65000 times (Google scholar Sept 2019). He is the recipient of the 2017 Bodossaki science prize, a highly cited researcher every year since 2014 and past president of the World Hellenic Biomedical Association. He has been invited to give talks and keynote lectures in all important genetics meeting and is the organizer of multiple training courses including the Wellcome Trust HapMap course and co-founder and co-organizer of the Leena Peltonen School of Human Genomics. He has served as an analysis co-chair in the pilot phase of the ENCODE (ENCyclopedia Of Dna Elements) consortium and member of the analysis group of the Mouse Genome Sequencing Consortium and the International HapMap project. He had a leading analysis role in the extension of the HapMap (HapMap3 project) and was a member of the analysis group of the 1000 genomes project and was a co-chair in the GTEx project. He is also member of the Organizing Committee of the International Common Disease Alliance. He has served in the Board of Reviewing Editors of Science (2006-2011) and as Senior Editor and now Consulting Editor in PLoS Genetic and he is currently the Editor-in-Chief of Frontiers in Genetics.